Scenario 1 A clinic receives a shipment of a newly marketed…
Scenario 1 A clinic receives a shipment of a newly marketed medication for chronic pain. During a review of the packaging, a health sciences intern notices that the product label lists the active ingredient and dosage but does not include a National Drug Code (NDC) number. The supervising provider explains that the medication was recently approved by the FDA and has undergone testing for safety and effectiveness. A patient asks why drug approval takes so long. Which action would be most appropriate if reports emerge that the medication causes serious unexpected adverse effects?